LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

Search

Cencora Inc

Gesloten

SectorGezondheidszorg

342.93 0.36

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

338.67

Max

343.72

Belangrijke statistieken

By Trading Economics

Inkomsten

-1B

-340M

Verkoop

3.1B

84B

K/W

Sectorgemiddelde

44.065

77.671

EPS

3.84

Dividendrendement

0.64

Winstmarge

-0.406

Werknemers

47,000

EBITDA

-1.1B

150M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+14.95% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.64%

2.35%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

1.9B

68B

Vorige openingsprijs

342.57

Vorige sluitingsprijs

342.93

Nieuwssentiment

By Acuity

5%

95%

1 / 374 Rangschikking in Healthcare

Cencora Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

16 dec 2025, 23:46 UTC

Marktinformatie

Gold Edges Higher, Aided by Fed Rate-Cut Prospects -- Market Talk

16 dec 2025, 23:38 UTC

Marktinformatie

Nikkei May Rise on Possible Bargain-Hunting Interest -- Market Talk

16 dec 2025, 22:35 UTC

Acquisities, Fusies, Overnames

Santos: Sale Delivered Cash, Reduced Future Decommissioning Exposure

16 dec 2025, 22:35 UTC

Acquisities, Fusies, Overnames

Santos Sold 43% Stake in Petrel Fields, 100% of Tern Fields to Eni Australia

16 dec 2025, 22:33 UTC

Acquisities, Fusies, Overnames

Santos: A$40M Upfront Consideration, Up to A$20M in Contingent Payments

16 dec 2025, 22:33 UTC

Acquisities, Fusies, Overnames

Santos Sold 43% Operated Interest in Mahalo JV to Comet Ridge

16 dec 2025, 22:32 UTC

Acquisities, Fusies, Overnames

Santos Divests Two Noncore Assets as Part of Portfolio Optimization

16 dec 2025, 22:25 UTC

Acquisities, Fusies, Overnames

Westgold's Indicative Timetable Points to Early February Completion

16 dec 2025, 22:24 UTC

Acquisities, Fusies, Overnames

Westgold: Divestment Aligns With Broader Corporate Strategy

16 dec 2025, 22:23 UTC

Acquisities, Fusies, Overnames

Westgold: Deferred Payment Based on Performance Hurdles

16 dec 2025, 22:23 UTC

Acquisities, Fusies, Overnames

Westgold Will Receive A$15M Cash, A$19.6M in Alicanto Shares

16 dec 2025, 22:23 UTC

Acquisities, Fusies, Overnames

Westgold to Receive A$30M Deferred Payment in Cash or Shares

16 dec 2025, 22:22 UTC

Acquisities, Fusies, Overnames

Westgold Divesting Noncore Operating Asset for A$64.6M

16 dec 2025, 22:22 UTC

Acquisities, Fusies, Overnames

Westgold Agrees to Sell Mt Henry-Selene Project to Alicanto Minerals

16 dec 2025, 21:53 UTC

Winsten

Lennar Misses Earnings Estimates. The Stock Is Dropping. -- Barrons.com

16 dec 2025, 21:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

16 dec 2025, 21:33 UTC

Acquisities, Fusies, Overnames

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- 2nd Update

16 dec 2025, 21:18 UTC

Acquisities, Fusies, Overnames

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- Update

16 dec 2025, 21:17 UTC

Acquisities, Fusies, Overnames

Worthington Enterprises to Buy LSI Group for About $205M >WOR

16 dec 2025, 21:16 UTC

Winsten

Worthington Enterprises 2Q Sales $327.5M >WOR

16 dec 2025, 21:16 UTC

Winsten

Worthington Enterprises 2Q Adj EPS 65c >WOR

16 dec 2025, 21:16 UTC

Winsten

Worthington Enterprises 2Q EPS 55c >WOR

16 dec 2025, 21:15 UTC

Acquisities, Fusies, Overnames

Worthington Enterprises Agrees To Acquire Leading Metal Roof Components Manufacturer LSI Group >WOR

16 dec 2025, 21:05 UTC

Acquisities, Fusies, Overnames

Ecolab Closes Acquisition Of Ovivo's Electronics Ultrapure Water Business >ECL

16 dec 2025, 20:54 UTC

Acquisities, Fusies, Overnames

Warner to Reject Paramount Offer As Soon As Wednesday, Sources Say -- WSJ

16 dec 2025, 20:54 UTC

Acquisities, Fusies, Overnames

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- WSJ

16 dec 2025, 20:54 UTC

Acquisities, Fusies, Overnames

Warner to Recommend Existing Netflix Deal, Sources Say -- WSJ

16 dec 2025, 20:44 UTC

Marktinformatie

Russia-Ukraine Peace Efforts Send Crude to Near 5-Year Low -- Market Talk

16 dec 2025, 20:04 UTC

Marktinformatie

U.S. Natural Gas Extends Weather-Driven Losing Streak -- Market Talk

16 dec 2025, 20:01 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Cencora Inc Prognose

Koersdoel

By TipRanks

14.95% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 392.82 USD  14.95%

Hoogste 417 USD

Laagste 361 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor Cencora Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

11 ratings

10

Buy

1

Hold

0

Sell

Sentiment

By Acuity

1 / 374 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat